About Us
Nebulabio is a specialized mammalian cell engineering team focused on developing high-performance stable HEK293 production cell lines for recombinant proteins, viral vectors, and gene therapy–related applications. Our approach integrates rational vector design, controlled integration strategies, high-throughput clone screening, and structured stability evaluation to deliver clonal HEK293 lines with defined productivity and consistent product quality.
☞Nebulabio High-performance CHO Platform
Our HEK293 platform is designed to combine human-compatible post-translational processing with improved stable productivity and reduced clonal variability. We support both episomal and integrating strategies, suspension-adapted serum-free workflows, and data-driven clone ranking to generate stable pools and monoclonal lines with reproducible performance. The resulting cell lines are engineered to function as reliable production systems rather than transient expression models.
☞Supported Options
HEK293 Host Cell Lines
| Expression Vector Systems
| |
Promoter and Expression Control
| Selection and Amplification
| |
Transfection and Enrichment
| High-throughput Screening and Analytics
|
☞Principle of High-performance HEK293 Stable Cell Line Development
High-performance HEK293 stable cell line development establishes a heritable expression chassis in a human-derived cellular background capable of authentic post-translational modification. Following delivery of an optimized expression cassette—either maintained episomally under selection or integrated into defined genomic loci—selective pressure enriches for stable transgene retention. Single-cell cloning isolates genetically homogeneous lines that balance productivity, growth characteristics, and product quality. Extended passaging without selection verifies transcriptional and phenotypic stability, ensuring that the final clone maintains reproducible performance across generations and culture conditions.
| ☎ +86-15801534258 | ✉ info@nebulabio.cn | Request a Quote ☜ |
☞Nebulabio Service Workflow
Project Design and Vector Construction We translate your molecule profile and production goals into a practical HEK293 development strategy aligned with downstream application needs. Key Steps
Transfection and Stable Pool Generation We establish stable transfected pools under defined selection conditions with early productivity tracking before cloning. Key Steps
Enrichment and Single-Cell Cloning We enrich productive populations and isolate monoclonal lines with documented clonal origin. Key Steps
High-throughput Clone Screening and Rank Ordering We screen and rank clones based on productivity, growth behavior, and early product quality signals. Key Steps
Lead Clone Characterization and Stability We confirm that top clones maintain productivity and quality over extended culture without selective pressure. Key Steps
Cell Banking and Documentation We generate bankable material with structured documentation to support internal use or transfer. Key Steps
|
☞Featured Applications
■ Recombinant Therapeutic Proteins Requiring Human-like Glycosylation
HEK293-derived stable cell lines are particularly suitable for proteins where human-type glycosylation influences efficacy or pharmacokinetics. Stable clones provide consistent glycan profiles across passages, reducing variability during analytical comparison and process development.
■ Adeno-associated Virus (AAV) Production Systems
Stable HEK293 producer lines configured for rep/cap and helper functions enable scalable vector production with reduced reliance on repeated plasmid transfection. This improves batch-to-batch consistency and simplifies upstream workflow design.
■ Lentiviral and Retroviral Vector Manufacturing
HEK293T-derived stable producer lines can support reproducible lentiviral vector generation for gene editing and cell therapy research. Eliminating transient transfection reduces variability and improves experimental comparability across production runs.
■ Multispecific Antibodies and Complex Fusion Proteins
Stable HEK293 clones support balanced multi-chain expression for bispecific antibodies, Fc-fusion proteins, and other complex formats. Human-compatible processing improves structural fidelity and functional consistency during development.
■ Gene Editing Enzymes and Biomanufacturing Reagents
Stable production of Cas variants, base editors, or transcription enzymes in HEK293 enables consistent reagent supply with controlled expression levels and documented clone identity.
| For more information, please contact us at info@nebulabio.cn or +86-15801534258. |
